🎙️ Science News Daily | Peer Review'd

Welcome to Peer Review'd, the podcast where we break down the latest science news and make sense of what researchers are discovering about our universe, our planet, and ourselves. I'm your host, and have we got a packed episode for you today. From spiral galaxies losing their cosmic identity to a pill that might replace your CPAP machine, let's dive in.

We're starting big — as in, universe-scale big. The Hubble Space Telescope has captured a breathtaking new image of Messier 88, a spiral galaxy that is, quite literally, being stripped of its future. M88 is hurtling toward the dense center of the Virgo Cluster — a massive congregation of galaxies — and the gravitational and gas-pressure forces there are slowly pulling away the raw material M88 would need to form new stars. It's called ram pressure stripping, and it's essentially cosmic erosion. The galaxy is losing its star-forming gas as it plunges deeper into the cluster. What Hubble has captured is a galaxy in transition — still beautiful, still spiraling, but slowly being transformed into something quieter and older. It's a reminder that even on galactic scales, nothing stays the same forever.

Staying in deep space, here's a detection that has astronomers genuinely excited. For the first time, researchers have spotted a closely orbiting pair of supermassive black holes in a galaxy called Markarian 501. Now, we've long suspected that pairs of supermassive black holes must exist — since most large galaxies have one at their center, galaxy mergers should create duos. But catching them in close orbit has been incredibly difficult. Scientists tracked two jets of particles emanating from the system to confirm the binary arrangement. Here's the kicker: this pair could merge within just 100 years. That's essentially tomorrow in cosmic time. And when they do, the collision will generate ripples in spacetime — gravitational waves — powerful enough that we may actually be able to detect them. This is exactly the kind of event that next-generation gravitational wave observatories are being designed to catch.

And while we're on cosmic explosions — NASA's Fermi Gamma-ray Space Telescope has caught a supernova doing something that has never been observed before. An international team of astronomers has found what appears to be the first-ever detection of gamma rays coming from a superluminous supernova — one of the rarest and most blindingly bright types of stellar explosions in the universe. This is a huge deal because scientists have long theorized that these extreme supernovae are powered by a rapidly spinning, highly magnetized neutron star called a magnetar. The gamma-ray detection from Fermi may finally be the smoking gun that confirms that theory. If magnetars really are the engines behind superluminous supernovae, this changes how we understand the life and death of the most massive stars.

Let's come down to Earth — or rather, deep into prehistory. Scientists have announced the discovery of a truly bizarre creature: a crocodile relative from the Triassic Period that walked upright on two legs, had a beak, and tiny arms, making it look far more like an ostrich than anything we'd recognize as a crocodile today. This is a fascinating window into just how wild the Triassic was — a time when evolution was essentially running wild experiments with body plans. The ancestors of crocodiles and dinosaurs shared a common lineage, and for a while, it wasn't obvious which group would dominate. This bipedal, beaked croc cousin is a reminder that the tree of life has some very strange branches.

And in another paleontology finding, meet Kank australis — a newly identified dinosaur from Patagonia that had the sharp claws of a raptor but apparently hunted like a giant prehistoric heron. Fossils suggest this creature waded through water, stalking and snatching fish with those formidable claws. It challenges the popular image of raptors as purely land-based pack hunters, showing that this group of dinosaurs had far more ecological diversity than we previously appreciated. Nature, it seems, found the heron body plan useful long before herons existed.

Now for some news that may change how you think about your medicine cabinet. A major review published in The BMJ is calling into question one of the most common health recommendations for older adults: taking calcium and vitamin D supplements to prevent fractures and falls. The review found that for most older adults, these supplements provide little to no meaningful benefit for bone fracture prevention. This doesn't mean calcium and vitamin D aren't important — they absolutely are — but it suggests that for many people who are already getting adequate amounts through diet and sunlight, adding supplements on top may not move the needle. Doctors may need to rethink blanket recommendations and focus on identifying who actually benefits.

In long COVID research, a brain imaging study out of Finland has delivered a surprising twist. Many scientists suspected that persistent long COVID symptoms — brain fog, fatigue, mood disturbances — were being driven by ongoing inflammation in the brain. But when researchers used advanced imaging to look at the brains of long COVID patients, they didn't find widespread inflammation. Instead, they found notable differences in the brain's emotion-processing centers. This is a significant finding because it shifts where we're looking for answers and potentially how we might treat these symptoms therapeutically.

On the cancer treatment front, researchers have identified a protein called NFIL3 that may be one of the biggest obstacles holding back CAR T-cell therapy — one of the most promising forms of cancer immunotherapy. CAR T therapy works by engineering a patient's own immune cells to hunt and destroy cancer cells, but over time, those cells get exhausted and lose their effectiveness. Scientists found that NFIL3 is a major driver of that exhaustion. When they disabled the protein in animal models, the engineered cells stayed stronger for longer and controlled tumors more effectively. This could be a pivotal step toward making CAR T therapy work for more patients and for longer.

If you or someone you love has struggled with sleep apnea and the notoriously uncomfortable CPAP machine, here's some genuinely hopeful news. A large phase 3 clinical trial has shown that a once-nightly pill significantly improved symptoms of obstructive sleep apnea. The drug works by targeting the biological mechanisms that cause the airway to collapse during sleep — addressing the root cause rather than just keeping the airway open mechanically the way a CPAP does. Results were presented at the 2026 ATS International Conference, and while the pill isn't replacing CPAPs just yet, this is a major step forward for the millions of people who find CPAP therapy difficult to stick with.

And we'll wrap up with something delightfully strange from the insect world. Scientists have been studying deer keds — blood-feeding flies that parasitize deer — and discovered a remarkable biological trade-off. These insects need their wings and sharp vision to find a host. But once they land on a deer and shed their wings permanently — yes, permanently — they dial down the activity of vision-related genes by about half. Researchers believe the flies are essentially trading eyesight for energy, redirecting biological resources toward feeding and reproduction now that navigation is no longer necessary. It's a striking example of how evolution can be ruthlessly pragmatic.

And how pigeons find their way home may finally have an answer too. A new study suggests that homing pigeons navigate using iron-rich immune cells in their livers that can respond to Earth's magnetic field. If confirmed, this would solve a decades-long mystery about bird navigation and reveal a remarkable new role for the immune system — not just defending the body, but helping it navigate the world.

That's a wrap on today's episode of Peer Review'd. From black holes on the verge of merging to pills that could replace your CPAP, science continues to surprise and amaze. Thanks for listening, stay curious, and we'll see you next time.